Hiroki Kato, PhD
*
Laboratory of Molecular Genetics, Institute for Virus Research
Kyoto university
53 Shogoinkawahara-cho, Sakyo-ku, Kyoto
606-8507 Japan
Phone: +81 (0)75-751-4033 E-mail: hkato@virus.kyoto-u.ac.jp
Current position
Associate professor in Kyoto University
Research expertise
My research focuses on the mechanisms by which cytoplasmic RNA sensors RIG-I like receptors (RLRs) distinguish
between viral RNAs and self-RNAs and trigger type I IFNs. Current work examines spontaneous autoimmune
symptoms in RLR mutant mice derived via mutagenesis and how RLR-dysregulation causes autoimmune disease.
I am also particularly interested in the analysis of immune responses and pathogenesis in virus infection in vivo and
autoimmune diseases using mouse models.
Academic qualifications
2005 - 2008 Doctorate, PhD The Department of Host Defense, Institute for Microbial Diseases, BIKEN,
Osaka University, Japan
2003 - 2005 Master
of Science, The Department of Host Defense, Institute for Microbial Diseases, BIKEN,
Osaka
University
2003
Bachelor of Science, Agricultural and life science, The University of Tokyo, Japan
Postgraduate professional career
2010 - pres. Associate Professor in Prof. Takashi Fujita’s lab, Institute for Virus Research, Kyoto University,
Japan
2008 - 2010 Postdoctoral fellow under Prof. Craig Mello, University of Massachusetts Medical School, USA
Honors and awards
2015
Highly cited researcher
2008 - 2010 Postdoctoral Fellowship for Research Abroad from Japan Society for the Promotion of Science
(JSPS)
2008
Yamamura Award,
Graduate School of Medicine, Osaka University
2005 - 2008 Research Fellowship for Young Scientists from Japan Society for the Promotion of Science
(JSPS)
Most important funding since 2012
2015 - 2017 AMED (rare autoimmune disease project)
2013 - 2017 AMED (HBV project)
2013 - 2016 Japan Science and Technology Agency (PRESTO)
2013 - 2014 Daiichi Sankyo Foundation of Life Science
Hiroki Kato,PhD
Publications
1.
Kato, H.
, and Fujita, T. (2015). RIG-I-like receptors and autoimmune diseases.
Curr Opin Immunol
37, 40-45.
2. Funabiki, M.°,
Kato, H.
°, Miyachi, Y., Toki, H., Motegi, H., Inoue, M., Minowa, O., Yoshida, A., Deguchi, K., Sato,
H., Ito, S., Shiroishi, T., Takeyasu, K., Noda, T., and Fujita, T. (2014). Autoimmune disorders associated with gain
of function of the intracellular sensor MDA5.
Immunity
40, 199-212. °equal contribution
3. Oda, H., Nakagawa, K., Abe, J., Awaya, T., Funabiki, M., Hijikata, A., Nishikomori, R., Funatsuka, M., Ohshima,
Y., Sugawara, Y., Yasumi, T.,
Kato, H.
, Shirai, T., Ohara, O., Fujita, T., and Heike, T. (2014). Aicardi-Goutieres
syndrome is caused by IFIH1 mutations.
Am J Hum Genet
95, 121-125.
4. Satoh, T.°,
Kato, H.
°, Kumagai, Y., Yoneyama, M., Sato, S., Matsushita, K., Tsujimura, T., Fujita, T., Akira, S., and
Takeuchi, O. (2010). LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses.
Proc Natl
Acad Sci U S A
107, 1512-1517. °equal contribution
5.
Kato, H.
, Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K., Hiiragi, A., Dermody, T.S., Fujita,
T., and Akira, S. (2008). Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-
inducible gene-I and melanoma differentiation-associated gene 5.
J Exp Med
205, 1601-1610.
6. Hornung, V., Ellegast, J., Kim, S., Brzozka, K., Jung, A.,
Kato, H.
, Poeck, H., Akira, S., Conzelmann, K.K.,
Schlee, M., Endres, S., and Hartmann, G. (2006). 5’-Triphosphate RNA is the ligand for RIG-I.
Science
314, 994-
997.
7.
Kato, H.
, Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T.,
Ishii, K.J., Yamaguchi, O., Otsu, K., Tsujimura, T., Koh, C.S., Reis e Sousa, C., Matsuura, Y., Fujita, T., and Akira,
S. (2006). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.
Nature
441, 101-105.
8. Kumar, H., Kawai, T.,
Kato, H.
, Sato, S., Takahashi, K., Coban, C., Yamamoto, M., Uematsu, S., Ishii, K.J.,
Takeuchi, O., and Akira, S. (2006). Essential role of IPS-1 in innate immune responses against RNA viruses.
J
Exp Med
203, 1795-1803.
9.
Kato, H.
, Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T.,
Takeuchi, O., and Akira, S. (2005). Cell type-specific involvement of RIG-I in antiviral response.
Immunity
23, 19-
28.
10. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H.,
Kato, H.
, Ishii, K.J., Takeuchi, O., and Akira, S. (2005).
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.
Nat Immunol
6, 981-988.